TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Outcome Assessment (Health Care)/methods
KW - United States
AU - J. J. Manlandro Jr
A1 - 
AB - The Drug Addiction Treatment Act of 2000 (DATA 2000) was established to create a new paradigm for medication-assisted treatment of persons with opiate addiction in the United States. Before enactment of DATA 2000, the use of opioid medications to treat patients with opioid addiction was permissible only in federally approved treatment programs, ie, "methadone clinics." The only medications permitted were Schedule II drugs (eg, methadone hydrochloride and l-alpha-acetylmethadol [LAAM]), which could only be dispensed, not prescribed. Under provisions of DATA 2000, qualified physicians in a medical office and other appropriate settings outside the opioid treatment program system may prescribe and/or dispense Schedule III, IV, and V opioid medications for treating persons with opioid addiction if such medications have been specifically approved by the US Food and Drug Administration for that indication. Opioid addiction treatment programs were commonly known as methadone clinics. Such programs now may also dispense buprenorphine hydrochloride and the buprenorphine hydrochloride-naloxone combination.
BT - The Journal of the American Osteopathic Association
C5 - Opioids & Substance Use; Healthcare Policy
CP - 9 Suppl 5
CY - United States
IS - 9 Suppl 5
JF - The Journal of the American Osteopathic Association
N2 - The Drug Addiction Treatment Act of 2000 (DATA 2000) was established to create a new paradigm for medication-assisted treatment of persons with opiate addiction in the United States. Before enactment of DATA 2000, the use of opioid medications to treat patients with opioid addiction was permissible only in federally approved treatment programs, ie, "methadone clinics." The only medications permitted were Schedule II drugs (eg, methadone hydrochloride and l-alpha-acetylmethadol [LAAM]), which could only be dispensed, not prescribed. Under provisions of DATA 2000, qualified physicians in a medical office and other appropriate settings outside the opioid treatment program system may prescribe and/or dispense Schedule III, IV, and V opioid medications for treating persons with opioid addiction if such medications have been specifically approved by the US Food and Drug Administration for that indication. Opioid addiction treatment programs were commonly known as methadone clinics. Such programs now may also dispense buprenorphine hydrochloride and the buprenorphine hydrochloride-naloxone combination.
PP - United States
PY - 2007
SN - 1945-1997; 0098-6151
EP - 6
EP - ES11+
T1 - Using buprenorphine for outpatient opioid detoxification
T2 - The Journal of the American Osteopathic Association
TI - Using buprenorphine for outpatient opioid detoxification
U1 - Opioids & Substance Use; Healthcare Policy
U2 - 17908825
VL - 107
VO - 1945-1997; 0098-6151
Y1 - 2007
ER -